4 results
Primary Trial Objective:To assess the effect of reversal of neuromuscular blockade with sugammadex 4 mg.kg-1 compared with reversal according to usual care (neostigmine or spontaneous reversal) on the incidence of adjudicated postsurgical events of…
Evaluating the long term safety and tolerability of ranibizumab treatment of AMD patients.
1. The primary objective of this study is to confirm the utility of the oVEMP cross-sectionally for the diagnosis of MG by reproducing the findings of Valko et al. in our cohort of MG patients and three control groups: healthy controls, controls…
To assess (i) the effect of partial neuromuscular blockade (NMB; TOF ratio 0.7) induced by low-dose rocuronium on the ventilatory response to isocapnic hypoxia and (ii) the effect of the reversal by sugammadex, neostigmine or placebo in healthy…